NCT00651664
- Conditions
- Advanced Malignancies
- Locations
-
- Ciutat Sanitaria Vall d'Hebron - Servicio de Oncologia Barcelona, Spain
- H. Clínico Universitario de Valencia Valencia, Spain
Clinical trial condition
Advanced Malignancies
Explore clinical trials studying Advanced Malignancies. Study availability and eligibility vary by location and protocol.
59 public trials
11 recruiting studies
Advanced Malignancies trial results
Completed
A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid Tumors
NCT00500903
- Conditions
- Advanced Malignancies
- Locations
-
- Sarah Cannon Research Institute (SCRI) Nashville, Tennessee, United States
NCT02678260
- Conditions
- Advanced Malignancies
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Kashiwa, Chiba, Japan
- Novartis Investigative Site Kobe, Hyōgo, Japan
NCT02013804
- Conditions
- Advanced Malignancies
- Locations
-
- Research Site New Haven, Connecticut, United States
- Research Site Detroit, Michigan, United States
- Research Site The Bronx, New York, United States
- Research Site Portland, Oregon, United States
Completed
A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies
NCT00741403
- Conditions
- Advanced Cancer, Advanced Malignancies, Disease Attributes, +15 more
- Locations
-
- Pivotal Research Centers Peoria, Arizona, United States
- Eastchester Center for Cancer Care The Bronx, New York, United States
- Mary Crowley Cancer Research Centers Dallas, Texas, United States
- British Columbia Cancer Agency Vancouver, British Columbia, Canada
NCT01284192
- Conditions
- Advanced Malignancies, B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Site US160 Orange, California, United States
- Site US184 Sacramento, California, United States
- Site US11 Chicago, Illinois, United States
- Site US2688 Detroit, Michigan, United States
NCT00948961
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Malignancies, +53 more
- Locations
-
- Yale Comprehensive Cancer Center New Haven, Connecticut, United States
- Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
- Henry Ford Health System Detroit, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00779428
- Conditions
- Advanced Malignancies
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT01930006
- Conditions
- Advanced Malignancies, Neoplasms
- Locations
-
- Vince & Associates Clinical Research, Inc. Overland Park, Kansas, United States
Completed
Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies
NCT00679133
- Conditions
- Advanced Malignancies, Neoplasms
- Locations
-
- Karmanos Cancer Institute Detroit, Michigan, United States
- University of Texas M.D. Anderson Cancer Center Houston, Texas, United States